Salivary metabolomics in oral cancer: A systematic review
Oral Oncology Reports · 2024-09 · 11 · 100657
DOI: 10.1016/j.oor.2024.100657 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Oral Oncology Reports, 2024-09. Verfasst von Rita Antonelli und 8 weiteren Autor:innen. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Diagnosis of oral squamous cell carcinoma (OSCC) is frequently delayed, with most tumors being detected in advanced stages. Saliva may represent the ideal fluid for early detection of dysplastic and malignant oral lesions. Among available salivary analytical approaches (e.g., genomic, transcriptomic, proteomic), metabolomics appears promising in identifying the presence of small, specific molecules directly released from malignant cells that could potentially serve as diagnostic biomarkers. This systematic review evaluates the scientific evidence that supports the role of salivary metabolites in the early diagnosis of OSCC. Medline, Scopus and Web of Science databases were searched until February 2024. Two independent reviewers assessed the quality of the studies using a checklist proposed by the National Institutes of Health. They also assessed the level of evidence using the Oxford Center for Evidence-Based Medicine classification. Twenty-eight out of 9623 papers fulfilled the inclusion and exclusion criteria. The quality of the included papers ranged from “good” (n = 2), “intermediate” (n = 22), and “poor” (n = 4). Ten out of 25 studies evaluated one specific metabolite (sialic acid, cortisol, pyruvic acid, neopterine, 8-hydroxy-2-deoxyguanosine and malondialdehyde, endogenous porphyrin, among others), with the remainder analyzing a combination of 2 or more molecules. Overall, the presence and/or concentration of more than 100 salivary metabolites was investigated in association with histologically confirmed diagnosis of OSCC. All studies showed a statistically significant correlation between one or more metabolites and OSCC. These results suggest that metabolic analysis of saliva is a promising field for early diagnosis of OSCC, even though more well-conducted studies are needed. • OSCC estimated 354,864 new cases and 177,384 related deaths in 2018. • Diagnosis OSCC is frequently delayed, with most tumors being detected in advanced stages. • Biomarkers associated to OSCC can be detected in saliva. • Sialic acid, neopterine, pyruvate, aspartate, glutamate, BCAA and cortisol seem promising biomarkers. • Further studies are necessary, considering the risk of bias highlighted in the review.
Zitieren
APA
Antonelli, R., Setti, G., Treister, N. S., Pertinhez, T. A., Ferrari, E., Gallo, M., Bologna-Molina, R., Vescovi, P., & Meleti, M. (2024). Salivary metabolomics in oral cancer: A systematic review. Oral Oncology Reports, 11, 100657. https://doi.org/10.1016/j.oor.2024.100657
Vancouver
Antonelli R, Setti G, Treister NS, Pertinhez TA, Ferrari E, Gallo M, et al. Salivary metabolomics in oral cancer: A systematic review. Oral Oncology Reports. 2024;11:100657. doi:10.1016/j.oor.2024.100657
BibTeX
@article{Antonelli2024,
author = {Antonelli, Rita and Setti, Giacomo and Treister, Nathaniel S. and Pertinhez, Thelma A. and Ferrari, Elena and Gallo, Mariana and Bologna-Molina, Ronell and Vescovi, Paolo and Meleti, Marco},
title = {Salivary metabolomics in oral cancer: A systematic review},
journal = {Oral Oncology Reports},
year = {2024},
volume = {11},
pages = {100657},
doi = {10.1016/j.oor.2024.100657}
}
EUVIMED